🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This single arm study will assess the maximum tolerated dose, and dose-limi...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00532948
Treatments Being Tested
The purpose of this study is to demonstrate that capecitabine/oxaliplatin a...
Status
Terminated
Location
Harbin Medical University Cancer Hospital
Start Date
2013-09
Trial ID
NCT01665274
Treatments Being Tested
The purpose of this study is to compare sacituzumab tirumotecan as a single...
Status
Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0066)
Start Date
2024-04-14
Trial ID
NCT06312176
The purpose of this study is to evaluate the pharmacokinetics (PK) of capec...
Status
Terminated
Location
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge Oncology Centre
Start Date
2009-11
Trial ID
NCT00871273
Treatments Being Tested
This multicenter study will assess the maximum tolerated dose (MTD) of cape...
Status
Terminated
Location
Fundacion Investigar
Start Date
2012-12-03
Trial ID
NCT01702558
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2004-12
Trial ID
NCT00112918
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-...
Status
Completed
Location
City of Hope ( Site 0005)
Start Date
2017-10-09
Trial ID
NCT03221426
Treatments Being Tested
Researchers are looking for new ways to treat people with head and neck can...
Status
Completed
Location
City of Hope ( Site 1519)
Start Date
2020-08-06
Trial ID
NCT04428151
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK) of adjuv...
Status
Completed
Location
Cambridge University Hospitals NHS Foundation Trust, University of Cambridge Oncology Centre
Start Date
2009-11
Trial ID
NCT00854477
Treatments Being Tested
Hypothesis: Patients with TYMS 2R/2R or 2R/3R appear to be more sensitive ...
Status
Completed
Location
National University Hospital
Start Date
2007-05
Trial ID
NCT00697502
Treatments Being Tested